Загрузка...
Treatment Strategies for Patients with Diffuse Large B-Cell Lymphoma: Past, Present, and Future
Diffuse large B-cell lymphoma (DLBCL) is the most commonly occurring lymphoma in the Western world. DLBCL is a clinically, biologically, and pathologically heterogeneous entity with biologically distinct subtypes that have different expected treatment outcomes. The addition of rituximab to combinati...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3606548/ https://ncbi.nlm.nih.gov/pubmed/23532092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S18701 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|